Joint Commission primary stroke center certification does not affect proband enrollment: the siblings with ischemic stroke study
- PMID: 19717020
- PMCID: PMC2748667
- DOI: 10.1016/j.jstrokecerebrovasdis.2009.01.005
Joint Commission primary stroke center certification does not affect proband enrollment: the siblings with ischemic stroke study
Abstract
Background: The Joint Commission (JC) certifies primary stroke centers in the United States. Whether certification promotes enrollment of study subjects into stroke research studies is not known. We examined whether enrollment performance of centers was related to JC certification status.
Methods: The 51 US Siblings with Ischemic Stroke Study (SWISS) centers were characterized by JC certification status, year of certification, year initiated into SWISS, center location, and whether the center had a vascular/stroke neurology fellowship program accredited by the Accreditation Council for Graduate Medical Education. Performance measures included days elapsed from initiation to first enrollment, total enrollments within 12 months after initiation, and annual rate of enrollment thereafter.
Results: In all, 36 of 51 SWISS sites (71%) were JC certified. A total of 32 (63%) were initiated into the study from 2000 through 2002, and 19 (37%) were initiated from 2005 through May 2008. Comparison of certified and noncertified sites showed no significant difference in the time to first enrollment (median, 77.5 v 115 days; P = .90), total enrollees in the first year (median, 3 v 2 probands; P = .69), or annual enrollment rate (median, 1.9 v 1.8 probands; P = .72). The rate of enrollment or time to first enrollment was not different between 2000-to-2002 and 2005-to-2008 sites. Early-initiated centers tended to have better year-1 enrollment than later-initiated centers (3 v 2 probands; P = .056).
Conclusions: JC certification did not have a significant effect on SWISS center enrollment. The JC should encourage the research mission among certified stroke centers.
References
-
- Kidwell CS, Liebeskind DS, Starkman S, et al. Trends in acute ischemic stroke trials through the 20th century. Stroke. 2001;32:1349–1359. - PubMed
-
- Amarenco P, Bogousslavsky J, Callahan A, III, et al. Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355:549–559. - PubMed
-
- Elkins JS, Khatabi T, Fung L, et al. Recruiting subjects for acute stroke trials: A meta-analysis. Stroke. 2006;37:123–128. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
